Medications

FDA approves first drug for rare form of rickets

(HealthDay)—Ultragenyx Pharmaceutical Inc.'s Crysvita (burosumab-twza) has been approved by the U.S. Food and Drug Administration to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH).

Health

Q&A: Insomnia—what to do when you can't sleep

Dear Mayo Clinic: What is the best way to eliminate insomnia? For almost a year, I've had trouble getting much sleep. I've tried over-the-counter medications, but they aren't very effective.

Neuroscience

Restless leg syndrome risk factor for heart-related death

Restless leg syndrome (RLS) is associated with increased risk of cardiovascular disease (CVD)-related death among women, according to research published online today (Dec. 15) in the January 2018 issue of Neurology, the medical ...

Health

Purpose in life by day linked to better sleep at night

Having a good reason to get out of bed in the morning means you are more likely to sleep better at night with less sleep apnea and restless leg syndrome, reports a new Northwestern Medicine and Rush University Medical Center ...

Health

Insomnia genes found

An international team of researchers has found, for the first time, seven risk genes for insomnia. With this finding the researchers have taken an important step towards the unravelling of the biological mechanisms that cause ...

Neuroscience

Sensory stimuli control dopamine in the brain

Regardless of whether we are sitting in a loud aeroplane or walking through a quiet forest clearing, how humans perceive their environment depends on the stimuli. This, in turn, affects our behaviour – sometimes consciously, ...

page 3 from 9